Campbell & Co Investment Adviser’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,162
Closed -$491K 1082
2022
Q4
$491K Buy
+26,162
New +$504K 0.12% 323
2022
Q3
Sell
-16,558
Closed -$289K 990
2022
Q2
$289K Buy
+16,558
New +$316K 0.08% 475
2021
Q4
Sell
-24,300
Closed -$343K 871
2021
Q3
$343K Buy
+24,300
New +$378K 0.11% 330
2018
Q4
Sell
-25,952
Closed -$521K 547
2018
Q3
$521K Buy
+25,952
New +$550K 0.35% 69
2015
Q2
Sell
-35,021
Closed -$560K 259
2015
Q1
$560K Buy
+35,021
New +$579K 0.35% 108

Other funds holding NXGN

Campbell & Co Investment Adviser's NXGN Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q1 2023, closing a stake of 26,162 shares — an estimated $491K sold.

Campbell & Co Investment Adviser first reported a position in NXGN in Q1 2015 and held it in 5 quarters. The position peaked at $560K in Q1 2015. 214 funds tracked by Wall St. Rank hold NXGN as of Q1 2023.

  • Campbell & Co Investment Adviser reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,162 NextGen Healthcare, Inc. Common Stock shares in Q1 2023, an estimated $491K.
  • Campbell & Co Investment Adviser first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's NextGen Healthcare, Inc. Common Stock position peaked at $560K in Q1 2015.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.